Keywords: rilutek, trial, parkinson, rhone-poulenc, rorer, riluzole, already

Rilutek trial in Parkinson's

Article | 11 February 1999

- Rhone-Poulenc Rorer's Rilutek (riluzole), already licensed foramyotrophic lateral sclerosis, is to be evaluated in patients with Parkinson's disease to see ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Rilutek

Riluzole

Go to drug listing